Latest stories on ATYR
aTyr Pharma Files Prospectus for Potential Stock Sales
TipRanks34 · bearishgeneral
aTYR PHARMA INC (ATYR) files 8-K
SEC 8-K50 · neutralgeneral
aTyr Pharma downgraded to Hold from Buy at Freedom Broker
The Fly34 · bearishanalyst
ATYR Maintains Rating by RBC Capital -- Price Target Lowered to $6.00
GuruFocus38 · neutralanalyst
ATYR Maintained by Wells Fargo -- Price Target Raised to $4.00
GuruFocus61 · neutralanalyst
aTyr Pharma price target lowered to split-adjusted $6 at RBC Capital
The Fly34 · bearishanalyst
Piper Sandler lowers aTyr Pharma stock price target on valuation
Investing.com Analyst Ratings34 · bearishanalyst
aTyr Pharma GAAP EPS of -$7.43 misses by $3.43
Seeking Alpha34 · bearishearnings
aTyr Pharma reports Q3 EPS ($7.43), consensus ($4.00)
The Fly74 · bullishearnings
aTYR PHARMA INC (ATYR) files 8-K
SEC 8-K50 · neutralgeneral
aTyr Pharma Announces Third Quarter 2026 Results and Provides Corporate Update
GlobeNewswire52 · neutralearnings
aTyr Pharma Announces Third Quarter 2026 Results and Provides Corporate Update
StockTitan52 · neutralearnings
3 Penny Stocks to Watch Today, November 2
TipRanks50 · neutralgeneral
aTyr Pharma Inc trading halted, news pending
The Fly50 · neutralgeneral
Atyr Pharma Announces 1 For 40 Reverse Stock Split
The Fly31 · bearishgeneral
aTYR PHARMA INC (ATYR) files 8-K
SEC 8-K50 · neutralgeneral
aTyr Pharma Announces One-for-40 Reverse Stock Split
GlobeNewswire31 · bearishgeneral
aTyr Pharma Announces Research Collaboration with Montefiore Einstein
Business Insider58 · neutralproduct/pr
aTYR PHARMA INC (ATYR) files 8-K
SEC 8-K50 · neutralgeneral
aTyr Pharma publishes ATYR0101 data in Journal of Biological Chemistry
The Fly56 · neutralproduct/pr
aTyr Pharma Announces Publication Demonstrating Anti-Fibrotic Effects of ATYR0101 in the Journal of Biological Chemistry
GlobeNewswire58 · neutralproduct/pr
Why is aTyr Pharma Stock (ATYR) Down 7% Today?
TipRanks38 · neutralgeneral
Why is aTyr Pharma stock surging today?
Investing.com Markets50 · neutralgeneral